By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal β†’
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal β†’
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Announcement: Small-Molecule Drugs Enable Safer, More Precise Therapeutic Genome Editing

Announcement: Small-Molecule Drugs Enable Safer, More Precise Therapeutic Genome Editing

GMJ
Last updated: 04/06/2026 11:52
By
Prof. Giorgi Pkhakadze
Share
0 Min Read
Illustration of small-molecule drugs controlling genome editing tools for safer gene therapy
New research shows small-molecule drugs can precisely control therapeutic genome editing, achieving 85% improved accuracy while reducing off-target effects by 67%. This breakthrough could revolutionize gene therapy safety and effectiveness. β€” Photo: www.kaboompics.com / Pexels
SHARE
1 min read|37 words

🧬 BREAKTHROUGH: Scientists develop safer gene therapy using small-molecule drugs to control genome editing! New system achieves 85% improved accuracy while reducing side effects by 67%. This could revolutionize treatment for genetic diseases.

Read the full article on GMJ Newsroom β†’

Was this article helpful?

GMJ Brief Β· Announcement

πŸ“° Read the full article: Small-Molecule Drugs Enable Safer, More Precise Therapeutic Genome Editing β†’

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper β†’

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript β†’
Carbohydrate Ingestion During Endurance Exercise: Meta-Analysis Shows Modest Glycogen Sparing Effect

A meta-analysis of 31 crossover trials reveals that carbohydrate ingestion during prolonged…

Caffeine Boosts Strength Through Neural Drive, Not Muscle Growthβ€”New Evidence

A randomized controlled trial shows caffeine enhances strength and power in resistance-trained…

How the gut absorbs nutrients: a seven-meter journey from mouth to colon

The human gastrointestinal tract divides into five specialized absorption zones, each extracting…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript β†’

You Might Also Like

Global map showing youth mortality rates by region with data visualization

What Healthcare Leaders Need to Know: Three Critical Findings from the Latest Youth Mortality Analysis

By
Prof. Giorgi Pkhakadze
05/07/2026
Medical illustration showing autoimmune disease impact on myelodysplastic syndrome outcomes

Study Quantifies Autoimmune Disease Impact on Myelodysplastic Syndrome Survival Outcomes

By
Prof. Giorgi Pkhakadze
24/06/2026
Portrait of Dr. Daniela Hozbor, Argentine biochemist researching pertussis vaccines

From Mar del Plata to Global Impact: Argentine Researcher Transforms Pertussis Vaccine Development

By
Prof. Giorgi Pkhakadze
21/06/2026
Medical imaging comparison showing enhanced MRI detecting small brain tumor missed by standard scan

What Patients and Clinicians Should Know About Advanced Brain Tumor Imaging

By
Prof. Giorgi Pkhakadze
07/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News β€” Click here

Join Community
Β© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up